Bolt Biotherapeutics, Inc. (BOLT) vs Imunon, Inc. (IMNN)
Bolt Biotherapeutics, Inc. and Imunon, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Imunon, Inc. are of similar size ($7.3M and $6.9M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against 0.00%. Imunon, Inc. has the higher net margin (0.00% vs −611.5%) and the lower return on invested capital (−324.4% vs −143.8%). Across the 18 metrics below, Bolt Biotherapeutics, Inc. leads on 11 and Imunon, Inc. on 7.
Valuation
Profitability
| Metric | BOLT | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (654.53%) | 0.00% | 0.00% |
| Net margin | (611.47%) | 0.00% | 0.00% |
| Free cash flow margin | (655.72%) | 0.00% | 0.00% |
| Return on equity | (111.65%) | (641.02%) | (57.72%) |
| Return on assets | (49.62%) | (123.93%) | (49.22%) |
| Return on invested capital | (143.75%) | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack